![](https://investorshub.advfn.com/uicon/144055.png?cb=1639680649)
Friday, May 21, 2021 2:32:42 PM
Added Many patents and trademarks to Nutra's portfolio
Clinical Trials in Multiple Phases
1. Multiple Sclerosis Trials
2. Herpes Simplex Infections 1 & 2 Trials
3. Adrenomyeloneuropathy Trials
4. HIV Trials
5. Amyotrophic Lateral Sclerosis Trials
6. Rheumatoid Arthritis Trials
7. Pain Trials
Products launched and brought to Market
1. Cobroxin
2. Nyloxin
3. Pet Pain Away
4. Equine pain Away
Published Research
http://receptopharm.com/drug_development/published_research.php
https://www.nutrapharma.com/research
Increased Sales on Amazon and Walmart
RPI-78M has received Orphan Drug Designation from the FDA for the treatment of Pediatric Multiple Sclerosis
Huge personal loans from Deitsch to NPHC tells me the CEO knows and believes in NPHC
Nyloxin, I put that Sh*t on everything!!! $NPHC
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM